Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials

Finding the Right Dose Using Patient-Reported Data in Early Phase Clinical Trials

Janet Freeman-Daily will lead a discussion and Q&A, following panel presentations by Dr. Bellinda King-Kallimanis (LUNGevity), Anne Loeser (PCDI, Patient Centered Dosing Initiative), Janice Cowden (PCDI), and Lee Jones (Patient/Survivor).

Educational Objectives:

  • Discover how drug makers have traditionally determined the dose for cancer drugs during early clinical trials
  • Find out how the FDA is planning to optimize the calculation of the dose for cancer drugs in the era of targeted therapies
  • Hear about the potential impact that patient experience data could have in optimizing the dose
  • Learn about the role patient research advocates can play in these discussions

Live interpretation will be offered in the below languages:

  • Chinese (Mandarin)
  • French
  • German
  • Greek
  • Japanese
  • Spanish (Latin America/neutral)

Please reach out to with any questions. We look forward to seeing you on August 24!

Aug 24, 2023 -
Aug 24, 2023

Thursday, August 24, 2023



Bellinda King-Kallimanis
Bellinda King-Kallimanis


Director of Patient-Focused Research
LUNGevity Foundation